课题基金 / 基金详情

SAFETY AND EFFICACY OF ADEFOVIR DIPIVOXIL (BIS-POM-PMEA) IN SURVIVAL--HIV

SAFETY AND EFFICACY OF ADEFOVIR DIPIVOXIL (BIS-POM-PMEA) IN SURVIVAL--HIV
阿德福韦酯 (BIS-POM-PMEA) 对 HIV 生存的安全性和有效性
批准号:
6282284
负责人:
CHERYL L BESCH
金额:
$1.97万
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-12-01 至 1999-06-30

项目摘要

项目成果

CHERYL L BESCH的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The purpose of this study is to determine if the investigational drug bis-POM PMEA is safe to give to people infected with HIV who have a CD4+ cell counts. This study is to also find out if bis-POM PMEA helps slow the growth of HIV and if bis-POM PMEA helps those infected live longer. The study will also look to determine if those not infected with CMV keep from developing CMV and to find out if a special test that looks at how much CMV is in the blood helps to predict which people with CMV may develop CMV disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
SAFETY AND EFFICACY OF ADEFOVIR DIPIVOXIL (BIS-POM-PMEA) IN SURVIVAL--HIV
  • 批准号:
    6122156
  • 项目类别:
  • 资助金额:
    $1.12万
  • 财政年份:
    1999
  • 负责人:
    CHERYL L BESCH
  • 依托单位:
CPCRA 059:IMPACT OF 2 DOSES OF SUBCUTANEOUS RECOMBINANT IL 2 ON VIRAL
  • 批准号:
    6265785
  • 项目类别:
  • 资助金额:
    $1.12万
  • 财政年份:
    1999
  • 负责人:
    CHERYL L BESCH
  • 依托单位:
CPCRA 046:EFFECTS OF ANTIRETROVIRAL MANAGEMENT BASED ON PLASMA GENOTY
  • 批准号:
    6265769
  • 项目类别:
  • 资助金额:
    $1.12万
  • 财政年份:
    1999
  • 负责人:
    CHERYL L BESCH
  • 依托单位:
CPCRA 045:EVALUATION OF HIV 1 GENOTYPIC RESISTANCE, VIRAL LOAD & CDS+
  • 批准号:
    6265778
  • 项目类别:
  • 资助金额:
    $1.12万
  • 财政年份:
    1999
  • 负责人:
    CHERYL L BESCH
  • 依托单位:
海外基金